Evolving progress in the management of malignant plasma cell disorders

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Article number	100612
Journal	Cancer Treatment and Research Communications
Volume	32
DOIs	https://doi.org/10.1016/j.ctarc.2022.100612
State	Published - Jan 2022

ASJC Scopus subject areas

@article{0a20cee74da84190a45eea20819d4e5f,

title = "Evolving progress in the management of malignant plasma cell disorders",

author = "Ezgi Atilgan and Gonsalves, {Wilson I.}",

year = "2022",

month = jan,

doi = "10.1016/j.ctarc.2022.100612",

language = "English (US)",

volume = "32",

journal = "Cancer Treatment and Research Communications",

issn = "2213-0896",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - Evolving progress in the management of malignant plasma cell disorders

AU - Atilgan, Ezgi

AU - Gonsalves, Wilson I.

PY - 2022/1

Y1 - 2022/1

UR - http://www.scopus.com/inward/record.url?scp=85134814537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85134814537&partnerID=8YFLogxK

U2 - 10.1016/j.ctarc.2022.100612

DO - 10.1016/j.ctarc.2022.100612

M3 - Editorial

C2 - 35872008

AN - SCOPUS:85134814537

SN - 2213-0896

VL - 32

JO - Cancer Treatment and Research Communications

JF - Cancer Treatment and Research Communications

M1 - 100612

ER -